Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Jayasree K. Iyer to speak at AMR 2026 Summit

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, will attend the AMR 2026 summit in Sydney, Australia, where she will speak at two sessions to share insights on the current antimicrobial resistance (AMR) landscape and solutions to current barriers from the Foundation's AMR research programme.

Date

18 February 2026

Location

Sydney

The AMR 2026 summit will convene global health leaders from the public, private and research sectors to discuss practical solutions to current challenges in mitigating antimicrobial resistance (AMR), providing a platform for stakeholders to share successful, replicable strategies for driving change.

Jayasree K. Iyer, CEO of the Access to Medicine Foundation, will be speaking at two sessions. On the first day of the summit, she will speak a panel entitled “The FAIRR initiative on AMR: What's next for investor action.” In this session, she will focus on how investors influence pharmaceutical companies’ level of engagement on AMR, highlighting policy recommendations and trends observed from the Foundation’s interactions with key industry players. Other panellists will include:

  • Fiona Reynolds, President, FAIRR

  • Debby Blakey, CEO, HESTA

  • Julie Orr, Non-Executive Director, SAAFE CRC and Australian Ethical Investments

On the second day, Jayasree will participate in the keynote session “From the Lab to the Last Mile and back again,” in which she will speak about the effects of stringent environmental requirements on smaller antibiotic manufacturers. She will also share insights on the industry’s current efforts and progress, drawing from the upcoming 2026 AMR Benchmark report, set to launch in March. Other participants will include:

  • Jas Chambers, Founder and Chair, Ocean Decade Australia

  • Elizabeth de Somer, CEO, Medicines Australia

  • Jaideep Gogtay, Global Chief Medical Officer, Cipla

  • Branwen Morgan, Lead, Minimising AMR, CSIRO

  • Susie Nilsson, Research Director, Biomedical Manufacturing, CSIRO

  • Michael Nunan, CEO, Beyond Essential Systems

  • Nelson Eduardo Soares Martins, Timor-Leste Lead, CAMO-Net

About the 2026 AMR Summit

In November 2021, Australia’s national science agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), hosted its first a virtual One Health AMR Summit, convening Australian experts from the public and private sectors to explore collaborative solutions to AMR. The invite-only 2026 AMR summit will feature expert speakers from around the world to discuss progress on goals and themes from the United Nations 2024 high-level meeting on AMR.

Research Hub

Explore our research reports and publications
Research

The methodology for the 2026 AMR Benchmark

28 January 2025
Research

Health & Wealth: The Investors’ Guide to Antimicrobial Resistance (AMR), a Growing Global Health Crisis

27 August 2024
Research

How can pharma get the few promising drugs in development to patients battling superbugs?

23 May 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved